Abstract
Naproxen at 10 mg per kg body weight was compared with aspirin at 80 mg per kg body weight in children suffering from juvenile chronic polyarthritis. It was found to be as effective as aspirin, with certainly no more and possibly fewer gastrointestinal side effects. A long-term tolerance study up to 12 months confirmed that naproxed was a satisfactory nonsteroidal anti-inflammatory drug in the management of various types of juvenile chronic arthritis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ANSELL B. M., BYWATERS E. G. Prognosis in Still's disease. Bull Rheum Dis. 1959 May;9(9):189–192. [PubMed] [Google Scholar]
- Ansell B. M., Hanna D. B., Stoppard M. Naproxen absorption in children. Curr Med Res Opin. 1975;3(1):46–50. doi: 10.1185/03007997509113646. [DOI] [PubMed] [Google Scholar]
- Ansell B. M. Ibuprofen in the management of Still's disease. Practitioner. 1973 Nov;211(265):659–663. [PubMed] [Google Scholar]
- Hill H. F., Hill A. G., Mowat A. G., Ansell B. M., Mathews J. A., Seifert M. H., Gumpel J. M., Christie G. A. Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis. Ann Rheum Dis. 1974 Jan;33(1):12–19. doi: 10.1136/ard.33.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]